Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

13,481 total articles

Do You Own Your Home—or Does It Own You? Angi Launches “Own It with Angie Hicks,” a Podcast That Coaches Homeowners on the Decisions No One Tells You About

Do You Own Your Home—or Does It Own You? Angi Launches “Own It with Angie Hicks,” a Podcast That Coaches Homeowners on the Decisions No One Tells You About

Angi Inc., a leading digital home services marketplace, announced the launch of a new podcast hosted by co-founder Angie Hicks titled 'Own It with Angie Hicks.' The podcast aims to coach homeowners on navigating the complex decisions involved in maintaining and improving their homes, featuring experts and industry insiders discussing topics such as…

APWC Announces Financial Results for the First Quarter of 2026

APWC Announces Financial Results for the First Quarter of 2026

Asia Pacific Wire & Cable Corporation Limited (APWC) announced financial results for Q1 2026 with revenues of $130.8 million, up 30% year-over-year but down 2% sequentially. EPS rose 171% year-over-year to $0.05 despite a 71% sequential decline. Revenue growth was driven by strong performance in international markets, especially Thailand and North …

Interlink Electronics Reports First Quarter 2026 Results

Interlink Electronics Reports First Quarter 2026 Results

Interlink Electronics announced its first quarter 2026 financial results, showing a 15.4% increase in revenue to $3.07 million compared to the prior year, along with improved gross margin of 43.5%. The company highlighted progress on a strategic acquisition, development of innovative wearable and medical sensor products, and plans to open a new R&D…

AiRWA Inc. Announces 1-for-40 Reverse Split

AiRWA Inc. Announces 1-for-40 Reverse Split

AiRWA Inc. announced it will execute a 1-for-40 reverse stock split of its common shares starting May 18, 2026. The reverse split will consolidate every 40 shares into one share, reducing the total outstanding shares to approximately 1.05 million while the ticker symbol (YYAI) remains unchanged. The move follows prior stockholder approval for a pot…

Progress Agentic RAG Named 2026 AI Excellence Award Winner for Advancing Retrieval-Augmented Generation

Progress Agentic RAG Named 2026 AI Excellence Award Winner for Advancing Retrieval-Augmented Generation

Progress Software's Agentic RAG, a SaaS platform designed to transform and govern unstructured data using Retrieval-Augmented Generation (RAG), has been named a winner in the 2026 Artificial Intelligence Excellence Awards. The award recognizes the platform's innovation in delivering practical, trustworthy AI solutions that accelerate productivity a…

LPL Financial Welcomes Fifteen:22 Financial Partners

LPL Financial Welcomes Fifteen:22 Financial Partners

LPL Financial announced that the financial advisors of Fifteen:22 Financial Partners, managing approximately $380 million in assets, have joined LPL's broker-dealer and Registered Investment Advisor platform. The partnership brings additional experienced advisors into LPL's network, enhancing its service capabilities with advanced technology and te…

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission

Curanex Pharmaceuticals reports key first quarter 2026 progress including completion of GMP-compliant manufacturing and dose-range toxicology studies for its lead drug candidate Phyto-N targeting ulcerative colitis. The company plans an Investigational New Drug (IND) submission to the FDA in Q4 2026 and has expanded its pipeline strategy to include…

Formula Systems Declares a Special Cash Dividend of $200 Million, or $13.045 Per Share, for Year 2025

Formula Systems Declares a Special Cash Dividend of $200 Million, or $13.045 Per Share, for Year 2025

Formula Systems (1985) Ltd., a global IT holding company listed on Nasdaq and the Tel Aviv Stock Exchange, declared a special cash dividend totaling approximately $200 million or $13.045 per share for the fiscal year 2025. The dividend reflects the company's successful performance, including the completion of the Sapiens acquisition by Advent, and …

Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase

Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase

Senti Biosciences Holdings, Inc. reported first quarter 2026 financial results highlighting a positive FDA meeting that supports a single-arm pivotal trial for SENTI-202 targeting relapsed/refractory AML. The company secured a strategic financing agreement for up to $40 million and made operational efficiencies leading to reduced net loss and cash …

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

AIM ImmunoTech released a virtual investor segment featuring expert insights and positive interim results for Ampligen in treating late-stage pancreatic cancer. The data from the Named Patient Program and ongoing Phase 2 trial suggest improvements in progression-free and overall survival, underlining Ampligen's potential as an immunotherapeutic opt…

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

Senti Biosciences reported a successful FDA RMAT meeting focusing on the registrational clinical and CMC strategy for SENTI-202, an off-the-shelf CAR-NK cell therapy for relapsed/refractory AML. The company revealed that selecting Donor X phenotype for manufacturing improves efficacy, showing a 50% composite complete remission rate, and plans a sin…

GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline

GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline

GRI Bio, Inc. announced positive Phase 2a clinical trial results for GRI-0621 in idiopathic pulmonary fibrosis (IPF), demonstrating significant reductions in cough, dyspnea, and treatment-related diarrhea, along with improved lung function and no serious adverse events. The company is progressing its GRI-0803 program for autoimmune diseases and rep…

Biogen Completes Acquisition of Apellis Pharmaceuticals

Biogen Completes Acquisition of Apellis Pharmaceuticals

Biogen Inc. has completed the acquisition of Apellis Pharmaceuticals, adding two commercialized complement-targeting therapies, EMPAVELI® and SYFOVRE®, which generated $689 million in 2025 revenue. This acquisition accelerates Biogen's expansion into nephrology and is expected to be accretive to non-GAAP diluted EPS in 2027, supporting stronger gro…

Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment

Neuronetics announces a strategic collaboration with ANT Neuro to integrate ANT Neuro's visor2 neuronavigation system with the NeuroStar Advanced Therapy System, enhancing real-time spatial tracking and 3D visualization for more precise and personalized transcranial magnetic stimulation (TMS) treatments. This partnership aims to improve treatment c…

Helport AI Launches New ‘AI Labor’ Corporate Website

Helport AI Launches New ‘AI Labor’ Corporate Website

Helport AI Limited has launched its next-generation AI-powered corporate website, demonstrating its flagship HyprX Expert Replication Engine. This new platform transforms traditional static websites into interactive AI labor environments, replicating expert human capabilities to enhance real-time customer interactions and enterprise workflows. Help…

Fiserv Leadership to Focus on Strategy, Execution Priorities and Financial Outlook at its 2026 Investor Day

Fiserv Leadership to Focus on Strategy, Execution Priorities and Financial Outlook at its 2026 Investor Day

Fiserv held its 2026 Investor Day presenting its One Fiserv action plan emphasizing disciplined strategy execution. The company projects adjusted and organic revenue growth of 1% to 3% for 2026 and forecasts medium-term compounded annual growth rates of 4% to 6%, with operating margins surpassing 37% by 2029. Fiserv expects adjusted earnings per sh…

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8

Prenetics Global Limited announces the appointment of Brian J. Rosin as U.S. Chief Financial Officer for IM8, its premium health and longevity brand co-founded with David Beckham. Rosin brings nearly 20 years of financial leadership in consumer e-commerce and wellness brands and will support IM8's rapid global expansion and financial strategy. IM8 …